Conclusion: Results presented in this report are indicative of a positive trend in compliance of pharmaceutical industries and clinical research groups to national regulations of CTs and IR-GCP.
← all excerpts
Regulatory aspects of clinical trials in iran: third year report of clinical trial committee in food and drug organization.
1
—
—